Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
clinical trials
life sciences
alexion pharmaceuticals
amyotrophic lateral sclerosis (als)
autoimmune disorders
biologic drugs
boston
boston blog main
boston top stories
boston xcon
boulder/denver xcon
complement system
deals
detroit xcon
digital health
drug development
fda
generalized myasthenia gravis
genome sequencing
healthtech
immune-mediated necrotizing myopathy
indiana xcon
innovation
national blog main
national xcon
new york xcon
patients
ra pharmaceuticals
raleigh-durham xcon
rare disease drugs
san diego
san diego xcon
san francisco xcon
seattle xcon
small molecule drugs
texas xcon
transcelerate biopharma
ucb
wisconsin xcon
What
drug
medicines
2
×
world
2
×
alternative
autoimmune
biologic
bottleneck
candidate
clinical
deal
development
disease
dramatically
expensive
fixing
genomic
lead
making
medicine
past
patients
pharma
pharmaceuticals
potential
priority
ra
sequencing
stakes
techn
territory
today
transformed
trial
ucb
viewed
years
Language
unset
Current search:
world
×
biotech
×
medicines
×
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
6 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority
